These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 15364232

  • 21. Uveitis masquerade syndromes: diffuse retinoblastoma in an older child.
    All-Ericsson C, Economou MA, Landau I, Träisk F, Seregard S.
    Acta Ophthalmol Scand; 2007 Aug; 85(5):569-70. PubMed ID: 17655613
    [No Abstract] [Full Text] [Related]

  • 22. Topotecan combination chemotherapy in two new rodent models of retinoblastoma.
    Laurie NA, Gray JK, Zhang J, Leggas M, Relling M, Egorin M, Stewart C, Dyer MA.
    Clin Cancer Res; 2005 Oct 15; 11(20):7569-78. PubMed ID: 16243833
    [Abstract] [Full Text] [Related]

  • 23. Orbital fibrosis and intraocular recurrence of retinoblastoma following periocular carboplatin.
    Kim JW, Yau JW, Moshfeghi D, Fishman M.
    J Pediatr Ophthalmol Strabismus; 2010 May 21; 47 Online():e1-4. PubMed ID: 21214147
    [Abstract] [Full Text] [Related]

  • 24. A 10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma.
    Bartuma K, Pal N, Kosek S, Holm S, All-Ericsson C.
    Acta Ophthalmol; 2014 Aug 21; 92(5):404-11. PubMed ID: 24119165
    [Abstract] [Full Text] [Related]

  • 25. Resolution of iris neovascularization following chemoreduction of advanced retinoblastoma.
    Shields CL, Sun H, Manquez ME, Leahey A, Meadows AT, Shields JA.
    Arch Ophthalmol; 2006 Aug 21; 124(8):1196-7. PubMed ID: 16908826
    [No Abstract] [Full Text] [Related]

  • 26. Retinoblastoma regression patterns following chemoreduction and adjuvant therapy in 557 tumors.
    Shields CL, Palamar M, Sharma P, Ramasubramanian A, Leahey A, Meadows AT, Shields JA.
    Arch Ophthalmol; 2009 Mar 21; 127(3):282-90. PubMed ID: 19273791
    [Abstract] [Full Text] [Related]

  • 27. Overview: chemotherapy for retinoblastoma: an expanding area of clinical research.
    Schouten-Van Meeteren AY, Moll AC, Imhof SM, Veerman AJ.
    Med Pediatr Oncol; 2002 Jun 21; 38(6):428-38. PubMed ID: 11984806
    [No Abstract] [Full Text] [Related]

  • 28. Chemoreduction in the management of retinoblastoma.
    Shields JA, Shields CL, Meadows AT.
    Am J Ophthalmol; 2005 Sep 21; 140(3):505-6. PubMed ID: 16139001
    [No Abstract] [Full Text] [Related]

  • 29. [Results of combined chemoreduction and local treatment for intraocular retinoblastoma].
    Kobylarz J, Piwowarczyk A, Romanowska-Dixon B, Balwierz W, Dłuzniewska A.
    Klin Oczna; 2006 Sep 21; 108(1-3):55-9. PubMed ID: 16883942
    [Abstract] [Full Text] [Related]

  • 30. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
    Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Singh A, Friedman DL, Naduvilath TJ.
    Am J Ophthalmol; 2002 May 21; 133(5):657-64. PubMed ID: 11992863
    [Abstract] [Full Text] [Related]

  • 31. Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapy.
    Sussman DA, Escalona-Benz E, Benz MS, Hayden BC, Feuer W, Cicciarelli N, Toledano S, Markoe A, Murray TG.
    Arch Ophthalmol; 2003 Jul 21; 121(7):979-84. PubMed ID: 12860801
    [Abstract] [Full Text] [Related]

  • 32. [Clinical therapeutic efficiency of chemoreduction and local therapy for children with retinoblastoma].
    Qian J, Xue K, Gao YJ, Yuan YF, Shan HD, Bi YW.
    Zhonghua Yan Ke Za Zhi; 2010 Apr 21; 46(4):312-6. PubMed ID: 20654057
    [Abstract] [Full Text] [Related]

  • 33. Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients.
    Dalvin LA, Bas Z, Tadepalli S, Rao R, Vaidya S, Pacheco R, Shields CL.
    J Pediatr Ophthalmol Strabismus; 2020 Jul 01; 57(4):224-234. PubMed ID: 32687206
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Selective ophthalmic arterial infusion of chemotherapeutic drugs for recurrent retinoblastoma.
    Trinavarat A, Chiewvit P, Buaboonnam J, Sanpakit K, Atchaneeyasakul LO.
    J Pediatr Hematol Oncol; 2012 Aug 01; 34(6):e218-21. PubMed ID: 22584782
    [Abstract] [Full Text] [Related]

  • 36. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
    Berry JL, Bechtold M, Shah S, Zolfaghari E, Reid M, Jubran R, Kim JW.
    Ophthalmology; 2017 Dec 01; 124(12):1817-1825. PubMed ID: 28655537
    [Abstract] [Full Text] [Related]

  • 37. Multifaceted chemotherapy for trilateral retinoblastoma.
    Dimaras H, Héon E, Doyle J, Strahlendorf C, Paton KE, Halliday W, Babyn P, Gallie BL, Chan HS.
    Arch Ophthalmol; 2011 Mar 01; 129(3):362-5. PubMed ID: 21402997
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.